Vimarsana
Biggest News Aggregation in the World

Amit Etkin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amit Etkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amit Etkin Today - Breaking & Trending Today

Alto Neuroscience to Present at the Jefferies Global Healthcare Conference - Vimarsana News

Alto Neuroscience to Present at the Jefferies Global Healthcare Conference

Alto Neuroscience, Inc. today announced that Company management will participate in the Jefferies Global Healthcare Conference, taking place June 5-6, 2024, in New York. Amit Etkin, M.D., Ph.D.,...

Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia - Vimarsana News

Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia

– ALTO-101 demonstrated a favorable pharmacokinetic and tolerability profile; novel transdermal formulation delivered significantly greater drug exposure and fewer adverse events typically...

Alto Neuroscience Appoints Maha Radhakrishnan, M.D., to Board of Directors - Vimarsana News

Alto Neuroscience Appoints Maha Radhakrishnan, M.D., to Board of Directors

– Experienced Medical and Executive Leader, Dr. Radhakrishnan served as Group SVP and Chief Medical Officer of Biogen, responsible for the Worldwide Medical function – ...

Alto Neuroscience to Present at the TD Cowen 44th Annual Healthcare Conference - Vimarsana News

Alto Neuroscience to Present at the TD Cowen 44th Annual Healthcare Conference

Alto Neuroscience, Inc. today announced that Amit Etkin, M.D., Ph.D., founder and chief executive officer, will present a company overview at the TD Cowen 44th Annual Healthcare Conference on...

Alto Neuroscience, Inc. IPO Offer Price Size Profile - Vimarsana News

Alto Neuroscience, Inc. IPO Offer Price Size Profile

Fundamental data and tools for long term investing, research and analysis for U.S. stocks, economy and indexes.

Source: ticker.com